Cite
Sayani A, Ismaila A, Walker A, et al. Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada. Can Urol Assoc J. 2014;8(1):E1-7doi: 10.5489/cuaj.755.
Sayani, A., Ismaila, A., Walker, A., Posnett, J., Laroche, B., Nickel, J. C., & Su, Z. (2014). Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 8(1), E1-7. https://doi.org/10.5489/cuaj.755
Sayani, Amyn, et al. "Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada." Canadian Urological Association journal = Journal de l'Association des urologues du Canada vol. 8,1 (2014): E1-7. doi: https://doi.org/10.5489/cuaj.755
Sayani A, Ismaila A, Walker A, Posnett J, Laroche B, Nickel JC, Su Z. Cost analysis of fixed-dose combination of dutasteride and tamsulosin compared with concomitant dutasteride and tamsulosin monotherapy in patients with benign prostatic hyperplasia in Canada. Can Urol Assoc J. 2014 Jan-Feb;8(1):E1-7. doi: 10.5489/cuaj.755. PMID: 24454593; PMCID: PMC3896551.
Copy
Download .nbib